KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Total Liabilities (2016 - 2025)

Cme (CME) has disclosed Total Liabilities for 17 consecutive years, with $169.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 52.93% to $169.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $169.7 billion, a 52.93% increase, with the full-year FY2025 number at $169.7 billion, up 52.93% from a year prior.
  • Total Liabilities was $169.7 billion for Q4 2025 at Cme, up from $159.0 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $178.2 billion in Q1 2022 to a low of $95.7 billion in Q2 2024.
  • A 5-year average of $136.7 billion and a median of $143.0 billion in 2022 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: skyrocketed 72.3% in 2021, then tumbled 35.11% in 2023.
  • Cme's Total Liabilities stood at $169.4 billion in 2021, then decreased by 13.04% to $147.3 billion in 2022, then tumbled by 30.09% to $103.0 billion in 2023, then increased by 7.76% to $111.0 billion in 2024, then surged by 52.93% to $169.7 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Total Liabilities are $169.7 billion (Q4 2025), $159.0 billion (Q3 2025), and $152.2 billion (Q2 2025).